Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) — Capital Reinvestment Ratio

Latest as of June 2023: 0.03x

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) has a Capital Reinvestment Ratio of 0.03x as of June 2023, meaning it reinvests 0% of its operating cash flow ($118.87 Million) in capital expenditures ($4.04 Million). See 900904 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.03x
Capex / Operating Cash Flow

Operating Cash Flow

$118.87 Million
USD

Capital Expenditures

$4.04 Million
USD

Data as of

Jun 2023
Most recent filing

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B Capital Reinvestment Ratio (2015–2024)

This chart tracks Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B's Capital Reinvestment Ratio across 10 annual periods.

Annual Capital Reinvestment Ratio for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (2015–2024)

Year-by-year Capital Reinvestment Ratio for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B from 2015 to 2024. For live market cap and broader valuation context, see Shanghai Shenqi Pharmaceutical Investmen (900904) market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2024 0.18x $207.79 Million $36.39 Million ▲ +54.0%
2023 0.11x $215.59 Million $24.51 Million ▲ +36.2%
2022 0.08x $319.23 Million $26.64 Million ▼ -82.1%
2021 0.47x $184.26 Million $85.96 Million ▼ -52.0%
2020 0.97x $99.10 Million $96.31 Million ▲ +62.0%
2019 0.60x $128.28 Million $76.96 Million ▼ -19.2%
2018 0.74x $148.53 Million $110.25 Million ▼ -54.3%
2017 1.62x $66.99 Million $108.84 Million ▼ -97.8%
2016 75.16x $570.41K $42.87 Million ▲ +3320.6%
2015 2.20x $30.12 Million $66.18 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow